SG11202007899QA - Ultra-sensitive detection of circulating tumor dna through genome-wide integration - Google Patents

Ultra-sensitive detection of circulating tumor dna through genome-wide integration

Info

Publication number
SG11202007899QA
SG11202007899QA SG11202007899QA SG11202007899QA SG11202007899QA SG 11202007899Q A SG11202007899Q A SG 11202007899QA SG 11202007899Q A SG11202007899Q A SG 11202007899QA SG 11202007899Q A SG11202007899Q A SG 11202007899QA SG 11202007899Q A SG11202007899Q A SG 11202007899QA
Authority
SG
Singapore
Prior art keywords
genome
ultra
circulating tumor
sensitive detection
tumor dna
Prior art date
Application number
SG11202007899QA
Other languages
English (en)
Inventor
Dan Avi Landau
Asaf Zviran
Original Assignee
Univ Cornell
New York Genome Center
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Cornell, New York Genome Center filed Critical Univ Cornell
Publication of SG11202007899QA publication Critical patent/SG11202007899QA/en

Links

Classifications

    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16BBIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B40/00ICT specially adapted for biostatistics; ICT specially adapted for bioinformatics-related machine learning or data mining, e.g. knowledge discovery or pattern finding
    • G16B40/20Supervised data analysis
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • GPHYSICS
    • G06COMPUTING; CALCULATING OR COUNTING
    • G06NCOMPUTING ARRANGEMENTS BASED ON SPECIFIC COMPUTATIONAL MODELS
    • G06N20/00Machine learning
    • GPHYSICS
    • G06COMPUTING; CALCULATING OR COUNTING
    • G06NCOMPUTING ARRANGEMENTS BASED ON SPECIFIC COMPUTATIONAL MODELS
    • G06N3/00Computing arrangements based on biological models
    • G06N3/02Neural networks
    • G06N3/08Learning methods
    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16BBIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B20/00ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16BBIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B20/00ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
    • G16B20/20Allele or variant detection, e.g. single nucleotide polymorphism [SNP] detection
    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16BBIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B25/00ICT specially adapted for hybridisation; ICT specially adapted for gene or protein expression
    • G16B25/10Gene or protein expression profiling; Expression-ratio estimation or normalisation
    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16HHEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/50ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for simulation or modelling of medical disorders
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/156Polymorphic or mutational markers

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Medical Informatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Theoretical Computer Science (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Molecular Biology (AREA)
  • Evolutionary Biology (AREA)
  • Analytical Chemistry (AREA)
  • Data Mining & Analysis (AREA)
  • Organic Chemistry (AREA)
  • Software Systems (AREA)
  • Pathology (AREA)
  • Evolutionary Computation (AREA)
  • Artificial Intelligence (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Computer Vision & Pattern Recognition (AREA)
  • General Engineering & Computer Science (AREA)
  • Databases & Information Systems (AREA)
  • Epidemiology (AREA)
  • Bioethics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Oncology (AREA)
  • Hospice & Palliative Care (AREA)
  • Biomedical Technology (AREA)
  • Computing Systems (AREA)
  • General Physics & Mathematics (AREA)
SG11202007899QA 2018-02-27 2019-02-27 Ultra-sensitive detection of circulating tumor dna through genome-wide integration SG11202007899QA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201862636135P 2018-02-27 2018-02-27
PCT/US2019/019905 WO2019169042A1 (fr) 2018-02-27 2019-02-27 Détection ultrasensible d'adn tumoral circulant par intégration à l'échelle du génome

Publications (1)

Publication Number Publication Date
SG11202007899QA true SG11202007899QA (en) 2020-09-29

Family

ID=67806402

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11202007899QA SG11202007899QA (en) 2018-02-27 2019-02-27 Ultra-sensitive detection of circulating tumor dna through genome-wide integration

Country Status (10)

Country Link
US (1) US20210043275A1 (fr)
EP (1) EP3759237A4 (fr)
JP (2) JP2021519607A (fr)
KR (1) KR20210009299A (fr)
CN (1) CN112601826A (fr)
AU (1) AU2019229273B2 (fr)
CA (1) CA3092343A1 (fr)
IL (1) IL276891A (fr)
SG (1) SG11202007899QA (fr)
WO (1) WO2019169042A1 (fr)

Families Citing this family (53)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10395772B1 (en) * 2018-10-17 2019-08-27 Tempus Labs Mobile supplementation, extraction, and analysis of health records
US11742064B2 (en) * 2018-12-31 2023-08-29 Tempus Labs, Inc. Automated quality assurance testing of structured clinical data
US20200340064A1 (en) * 2019-04-16 2020-10-29 Grail, Inc. Systems and methods for tumor fraction estimation from small variants
WO2021016441A1 (fr) * 2019-07-23 2021-01-28 Grail, Inc. Systèmes et procédés de détermination d'une fraction tumorale
EP4025706A4 (fr) * 2019-09-05 2023-10-18 Fabric Genomics, Inc. Procédés d'analyse de variants génétiques basés sur un matériau génétique
CN110659599A (zh) * 2019-09-19 2020-01-07 安徽七天教育科技有限公司 一种基于扫描试卷的离线笔迹鉴定系统以及使用方法
CN110808081B (zh) * 2019-09-29 2022-07-08 深圳吉因加医学检验实验室 一种鉴定肿瘤纯度样本的模型构建方法及应用
EP4041924A1 (fr) * 2019-10-08 2022-08-17 Illumina, Inc. Caractérisation de taille de fragment de mutations d'adn acellulaire provenant d'une hématopoïèse clonale
US20240186001A1 (en) * 2019-10-16 2024-06-06 Icahn School Of Medicine At Mount Sinai Systems and methods for detecting a disease condition
CN110890132A (zh) * 2019-11-19 2020-03-17 湖南大学 基于自适应高斯混合模型的癌症突变簇识别方法
AU2021208683A1 (en) * 2020-01-16 2022-08-18 Congenica Ltd. Application of pathogenicity model and training thereof
CN111310680B (zh) * 2020-02-24 2022-11-04 电子科技大学 一种基于深度学习的辐射源个体识别方法
EP4118653A1 (fr) * 2020-03-11 2023-01-18 Guardant Health, Inc. Procédés de classification de mutations génétiques détectées dans des acides nucléiques acellulaires en tant qu'origine tumorale ou non tumorale
CN111341383B (zh) * 2020-03-17 2021-06-29 安吉康尔(深圳)科技有限公司 一种检测拷贝数变异的方法、装置和存储介质
KR102309277B1 (ko) * 2020-03-26 2021-10-07 주식회사 클리노믹스 이종생물 유래의 유전자 마커 매칭에 기반한 하나 혹은 그 이상의 모델생물의 유전자 마커와 그 패턴 정보를 목표하는 생물의 유전자 마커 정보로 이용하는 유전자 검사 서비스 제공 방법
EP4162417A1 (fr) 2020-06-03 2023-04-12 Xenotherapeutics, Inc. Procédés de sélection et de surveillance en vue d'une xénogreffe
CN116157868A (zh) * 2020-08-18 2023-05-23 德尔菲诊断公司 用于游离dna片段大小密度以评估癌症的方法和系统
CN112285565B (zh) * 2020-09-21 2021-07-13 电子科技大学 基于rkhs域匹配的迁移学习预测电池soh方法
WO2022168195A1 (fr) * 2021-02-03 2022-08-11 国立大学法人東北大学 Système d'analyse d'informations génétiques et procédé d'analyse d'informations génétiques
WO2022178337A1 (fr) * 2021-02-19 2022-08-25 Tempus Labs, Inc. Diagnostics moléculaires longitudinaux détectant des mutations de réversion somatique
CN113113085B (zh) * 2021-03-15 2022-08-19 杭州杰毅生物技术有限公司 基于智能宏基因组测序数据肿瘤检测的分析系统及方法
CN112951418B (zh) * 2021-05-17 2021-08-06 臻和(北京)生物科技有限公司 基于液体活检的连锁区域甲基化评估方法和装置、终端设备及存储介质
CN113496762B (zh) * 2021-05-20 2022-09-27 山东大学 一种生物基因序列的概要数据生成方法及系统
CN113257350B (zh) * 2021-06-10 2021-10-08 臻和(北京)生物科技有限公司 基于液体活检的ctDNA突变程度分析方法和装置、ctDNA性能分析装置
CN113096728B (zh) * 2021-06-10 2021-08-20 臻和(北京)生物科技有限公司 一种微小残余病灶的检测方法、装置、存储介质及设备
CN113362894A (zh) * 2021-06-15 2021-09-07 上海基绪康生物科技有限公司 一种对协同致死的癌症驱动基因进行预测的方法
CN113470746B (zh) * 2021-06-21 2023-11-21 广州市金域转化医学研究院有限公司 降低高通量测序中人工引入错误突变的方法及应用
EP4359569A1 (fr) * 2021-06-22 2024-05-01 Foundation Medicine, Inc. Systèmes et procédés d'évaluation d'une fraction tumorale
CN113539355B (zh) * 2021-07-15 2022-11-25 云康信息科技(上海)有限公司 预测cfDNA的组织特异性来源及相关疾病概率评估系统及应用
EP4385021A1 (fr) * 2021-08-10 2024-06-19 Cornell University Biopsie liquide ultrasensible par séquençage du génome entier du plasma grâce à l'apprentissage profond
CN118043670A (zh) * 2021-08-25 2024-05-14 X基因组公司 随机表观基因组采样
CN113903398A (zh) * 2021-09-08 2022-01-07 南京世和基因生物技术股份有限公司 肠癌早筛标志物、检测方法、检测装置以及计算机可读取介质
WO2023043914A1 (fr) * 2021-09-15 2023-03-23 The Broad Institute, Inc. Diagnostic et pronostic du syndrome de richter
CN113903401B (zh) * 2021-12-10 2022-04-08 臻和(北京)生物科技有限公司 基于ctDNA长度的分析方法和系统
WO2023133093A1 (fr) * 2022-01-04 2023-07-13 Cornell University Enrichissement de signal guidé par apprentissage automatique pour surveillance de charge tumorale au plasma ultrasensible
CN114446386B (zh) * 2022-01-17 2024-02-02 中国人民解放军国防科技大学 一种血液ctDNA的检测方法
KR20230172174A (ko) * 2022-06-15 2023-12-22 주식회사 지씨지놈 무세포 핵산의 단일염기변이를 이용한 암 진단 및 암 종 예측방법
US20240021267A1 (en) * 2022-07-18 2024-01-18 Grail, Llc Dynamically selecting sequencing subregions for cancer classification
US20240071565A1 (en) * 2022-08-31 2024-02-29 Saga Diagnostics Ab Structural variant identification
CN115294231B (zh) * 2022-09-29 2023-02-03 浙江省肿瘤医院 一种胃癌错配修复基因缺陷的预测方法
CN115558716B (zh) * 2022-09-29 2023-11-03 南京医科大学 一种用于预测癌症的cfDNA片段特征组合、系统及应用
WO2024086515A1 (fr) * 2022-10-17 2024-04-25 Foundation Medicine, Inc. Procédés et systèmes de prédiction d'un site de maladie primaire cutanée
WO2024089689A1 (fr) * 2022-10-25 2024-05-02 Clonal Ltd Méthodes de détection du cancer du sein
WO2024091545A1 (fr) * 2022-10-25 2024-05-02 Cornell University Suppression d'erreur d'acide nucléique
CN115406815B (zh) * 2022-11-02 2023-02-03 杭州华得森生物技术有限公司 基于多源数据融合的肿瘤细胞检测设备及其方法
CN115595371B (zh) * 2022-12-07 2023-04-11 元码基因科技(北京)股份有限公司 确定结直肠癌患者msi状态的方法及应用
CN115690109B (zh) * 2023-01-04 2023-03-14 杭州华得森生物技术有限公司 基于计算生物的肿瘤细胞检测设备及其方法
CN116386903B (zh) * 2023-06-06 2023-11-10 中国医学科学院肿瘤医院 一种小细胞肺癌肿瘤间和肿瘤内异质性解读方法
CN116863998B (zh) * 2023-06-21 2024-04-05 扬州大学 一种基于遗传算法的全基因组预测方法及其应用
CN116895332B (zh) * 2023-09-11 2023-12-05 臻和(北京)生物科技有限公司 一种酶切法打断建库中人工片段产生的假阳性突变的过滤方法
CN117253546B (zh) * 2023-10-11 2024-05-28 北京博奥医学检验所有限公司 一种降低靶向二代测序背景噪音的方法、系统及可存储介质
CN117373678B (zh) * 2023-12-08 2024-03-05 北京望石智慧科技有限公司 基于突变签名的疾病风险预测模型构建方法及分析方法
CN117976045B (zh) * 2024-03-29 2024-06-14 鲁东大学 一种基于基因突变数据的癌症转移相关基因预测方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10236078B2 (en) * 2008-11-17 2019-03-19 Veracyte, Inc. Methods for processing or analyzing a sample of thyroid tissue
EP2891099A4 (fr) * 2012-08-28 2016-04-20 Broad Inst Inc Détection de variants dans des données de séquençage et un étalonnage
ES2923602T3 (es) * 2014-12-31 2022-09-28 Guardant Health Inc Detección y tratamiento de enfermedades que muestran heterogeneidad celular de enfermedad y sistemas y métodos para comunicar los resultados de las pruebas
US10815522B2 (en) * 2015-02-20 2020-10-27 The Johns Hopkins University Genomic alterations in the tumor and circulation of pancreatic cancer patients
US10364468B2 (en) * 2016-01-13 2019-07-30 Seven Bridges Genomics Inc. Systems and methods for analyzing circulating tumor DNA
US10095831B2 (en) * 2016-02-03 2018-10-09 Verinata Health, Inc. Using cell-free DNA fragment size to determine copy number variations
WO2017161175A1 (fr) * 2016-03-16 2017-09-21 Dana-Farber Cancer Institute, Inc. Procédés pour la caractérisation de génomes
GB201607629D0 (en) * 2016-05-01 2016-06-15 Genome Res Ltd Mutational signatures in cancer
JP6963009B2 (ja) * 2016-05-19 2021-11-05 オンコスカー エルエルシーOncoscar Llc 臨床的に難治性の悪性腫瘍の診断及び治療標的化の方法
CN107447258A (zh) * 2016-06-01 2017-12-08 大连医科大学 循环肿瘤dna靶向基因高通量检测文库及其检测方法和应用
CN105950750A (zh) * 2016-06-08 2016-09-21 福州市传染病医院 用于肝癌诊断及预后评估的基因群及试剂盒

Also Published As

Publication number Publication date
EP3759237A1 (fr) 2021-01-06
IL276891A (en) 2020-10-29
CN112601826A (zh) 2021-04-02
WO2019169042A1 (fr) 2019-09-06
KR20210009299A (ko) 2021-01-26
AU2019229273B2 (en) 2023-04-27
CA3092343A1 (fr) 2019-09-06
AU2019229273A1 (en) 2020-09-10
JP2021519607A (ja) 2021-08-12
EP3759237A4 (fr) 2022-06-01
JP2024019413A (ja) 2024-02-09
US20210043275A1 (en) 2021-02-11

Similar Documents

Publication Publication Date Title
IL276891A (en) Highly sensitive detection of circulating DNA through genome-wide integration
HK1243764A1 (zh) 用於富集循環腫瘤dna的方法
ZA201804322B (en) Deep sequencing profiling of tumors
PL3259598T3 (pl) Wielofunkcyjne magneto-polimeryczne nanosystemy do szybkiego celowania w krążące komórki nowotworowe, ich izolacji, wykrywania i jednoczesnego obrazowania
IL280603A (en) Discovery of nucleic acids in vitro
IL255714B (en) Discovery of designated nucleic acids and their variants
SG11202112523UA (en) Detection of colorectal cancer
IL254687A0 (en) A bio-sensor system for rapid identification of an analyte
GB2571026B (en) Detection of PH
SG10201912967YA (en) Determination of nucleic acid methylation
EP3094767A4 (fr) Utilisation d'agents d'acides nucléiques pour détection et quantification numériques ultrasensibles de molécules cibles
SG11202112522TA (en) Detection of colorectal cancer
EP3562961A4 (fr) Compositions et procédés de détection d'adn tumoral circulant
GB201602210D0 (en) Detection of cancer
EP3596467C0 (fr) Détection, quantification et/ou isolement de cellules tumorales circulantes sur la base de l'expression du marqueur cd321
EP3100053A4 (fr) Procédés pour la détection et la quantification de mimétiques de cellules tumorales circulantes
IL255081A0 (en) Identification of nucleic acid molecules
EP3286339A4 (fr) Sondes à base d'oligonucléotide pour la détection de nucléases de cellules tumorales circulantes
PT3298165T (pt) Método e kit para diagnóstico de cancro colorretal
GB201905861D0 (en) Methods of detecting cancer
EP3183366A4 (fr) Systèmes et procédés de détection d'un cancer à tumeur solide
IL281037A (en) Methods of detecting nucleic acid
HK1246851A1 (zh) 檢測癌症的方法
GB2552535B (en) Detection of scatter radiation
SG10201603579PA (en) Methods Of Detecting Cancer